Literature DB >> 7758006

Compliance with oral chemotherapy in childhood lymphoblastic leukaemia.

H A Davies1, J S Lilleyman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7758006     DOI: 10.1016/0305-7372(95)90022-5

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN: 0305-7372            Impact factor:   12.111


× No keyword cloud information.
  11 in total

Review 1.  The oral route for the administration of cytotoxic drugs: strategies to increase the efficiency and consistency of drug delivery.

Authors:  H A Bardelmeijer; O van Tellingen; J H Schellens; J H Beijnen
Journal:  Invest New Drugs       Date:  2000-08       Impact factor: 3.850

2.  Pediatric Cancer CareLink--supporting home management of childhood leukemia.

Authors:  D M Goldsmith; L B Silverman; C Safran
Journal:  Proc AMIA Symp       Date:  2002

3.  A Systematic Review of Rates, Outcomes, and Predictors of Medication Non-Adherence Among Adolescents and Young Adults with Cancer.

Authors:  Meghan E McGrady; Ahna L H Pai
Journal:  J Adolesc Young Adult Oncol       Date:  2019-04-30       Impact factor: 2.223

4.  A grounded theory of the process of adherence to oral chemotherapy in Hispanic and caucasian children and adolescents with acute lymphoblastic leukemia.

Authors:  Wendy Landier; Cynthia B Hughes; Evelyn R Calvillo; Nancy L R Anderson; Deborah Briseño-Toomey; Leticia Dominguez; Alex M Martinez; Cara Hanby; Smita Bhatia
Journal:  J Pediatr Oncol Nurs       Date:  2011-06-08       Impact factor: 1.636

Review 5.  Oral cancer chemotherapy in paediatric patients: obstacles and potential for development and utilisation.

Authors:  W A Bleyer; M G Danielson
Journal:  Drugs       Date:  1999       Impact factor: 9.546

6.  Compliance with a protocol for acute lymphoblastic leukemia in childhood.

Authors:  Benigna Maria de Oliveira; Maria Thereza Macedo Valadares; Marcilene Rezende Silva; Marcos Borato Viana
Journal:  Rev Bras Hematol Hemoter       Date:  2011

7.  Clinical and laboratory evaluation of compliance in acute lymphoblastic leukaemia.

Authors:  B M de Oliveira; M B Viana; C L Zani; A J Romanha
Journal:  Arch Dis Child       Date:  2004-08       Impact factor: 3.791

8.  The development of an objective methodology to measure medication adherence to oral thiopurines in paediatric patients with acute lymphoblastic leukaemia--an exploratory study.

Authors:  Ahmed F Hawwa; Jeff S Millership; Paul S Collier; Anthony McCarthy; Sid Dempsey; Carole Cairns; James C McElnay
Journal:  Eur J Clin Pharmacol       Date:  2009-07-28       Impact factor: 2.953

9.  Adherence to 6-Mercaptopurine in children and adolescents with Acute Lymphoblastic Leukemia.

Authors:  Mervat Alsous; Rana Abu Farha; Eman Alefishat; Suha Al Omar; Deema Momani; Alia Gharabli; James McElnay; Robert Horne; Rawad Rihani
Journal:  PLoS One       Date:  2017-09-06       Impact factor: 3.240

10.  Intracellular metabolites of mercaptopurine in children with lymphoblastic leukaemia: a possible indicator of non-compliance?

Authors:  L Lennard; J Welch; J S Lilleyman
Journal:  Br J Cancer       Date:  1995-10       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.